FIELD: biochemistry.
SUBSTANCE: invention relates to a method of replenishing plasminogen in a plasminogen deficient individual, wherein the plasminogen deficient patient has reduced plasma plasminogen activity relative to normal plasma plasminogen activity. Also disclosed is the use of Glu-plasminogen for preparing a drug for replenishing plasminogen in a subject with plasminogen deficiency, having reduced plasma plasminogen activity relative to normal plasma plasminogen activity.
EFFECT: invention provides effective replacement of plasminogen in a subject with plasminogen deficiency.
40 cl, 6 tbl, 7 ex, 25 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PLASMINOGEN FOR TREATMENT AND PREVENTION OF MICROTHROMBOSIS | 2020 |
|
RU2813699C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING PLASMINOGEN, AND USE THEREOF | 2015 |
|
RU2711989C2 |
| VERSIONS OF PLASMINOGEN AND PLASMIN | 2010 |
|
RU2564131C2 |
| PLASMINOGEN AND PLASMIN VARIANTS | 2012 |
|
RU2604807C2 |
| PLASMINOGEN AND PLASMIN VARIANTS | 2012 |
|
RU2604810C2 |
| METHODS OF TREATING TISSUE CALCIFICATION | 2015 |
|
RU2770698C2 |
| PHARMACEUTICAL COMPOSITION FOR GROWTH HORMONE DEFICIENCY THERAPY COMPRISING FUSED hGH PROTEIN | 2017 |
|
RU2748402C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING RECOMBINANT HUMAN GROWTH HORMONE FOR TREATING GROWTH HORMONE DEFICIENCY | 2017 |
|
RU2732113C2 |
| METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION AND ISCHEMIC DAMAGE | 2012 |
|
RU2638807C2 |
| USING ACID LYSOSOME LIPASE FOR TREATING ACID LYSOSOME LIPASE DEFICIENCY IN PATIENTS | 2011 |
|
RU2550961C2 |
